Edward J Dulac Iii Fate Therapeutics Inc (FATE) insider trading activity

Edward J Dulac Iii is Chief Financial Officer of FATE THERAPEUTICS INC. Currently has a direct ownership of 101,479 shares of FATE, which is worth approximately $332,851. The most recent transaction as insider was on Mar 04, 2024, when has been sold 2,447 shares (Common Stock) at a price of $7.77 per share, resulting in proceeds of $19,013. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K

0% 3M change

21.62% 12M change

Total Value Held $332,851

Edward J Dulac III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2024	SELL Open market or private sale	$19,013 $7.77 p/Share	2,447 Reduced 2.35%	101,479 Common Stock
Jan 29 2024	SELL Open market or private sale	$9,245 $5.0 p/Share	1,849 Reduced 1.75%	103,926 Common Stock
Jan 09 2024	SELL Open market or private sale	$30,712 $4.37 p/Share	7,028 Reduced 6.23%	105,775 Common Stock
Jan 02 2024	SELL Open market or private sale	$18,966 $3.66 p/Share	5,182 Reduced 4.39%	112,803 Common Stock
Dec 18 2023	SELL Open market or private sale	$5,547 $3.5 p/Share	1,585 Reduced 1.33%	117,985 Common Stock
Aug 18 2023	SELL Open market or private sale	$13,210 $2.8 p/Share	4,718 Reduced 3.8%	119,570 Common Stock
Jul 05 2023	SELL Open market or private sale	$25,029 $4.83 p/Share	5,182 Reduced 4.0%	124,288 Common Stock

Jan 10 2023	SELL Open market or private sale	$38,414 $5.24 p/Share	7,331 Reduced 5.36%	129,470 Common Stock
Aug 18 2022	SELL Open market or private sale	$154,461 $30.08 p/Share	5,135 Reduced 3.62%	136,801 Common Stock
Jan 25 2022	BUY Grant, award, or other acquisition	-	33,302 Added 19.0%	141,936 Common Stock
Jan 11 2022	SELL Open market or private sale	$86,217 $48.71 p/Share	1,770 Reduced 1.6%	108,634 Common Stock
Dec 20 2021	SELL Open market or private sale	$958,620 $60.0 p/Share	15,977 Reduced 12.64%	110,404 Common Stock
Dec 20 2021	BUY Exercise of conversion of derivative security	$512,802 $35.52 p/Share	14,437 Added 10.25%	126,381 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	59,540 Added 34.72%	111,944 Common Stock
Sep 28 2021	SELL Open market or private sale	$1,216,834 $62.53 p/Share	19,460 Reduced 27.08%	52,404 Common Stock
Sep 28 2021	BUY Exercise of conversion of derivative security	$615,384 $35.52 p/Share	17,325 Added 19.43%	71,864 Common Stock
Aug 19 2021	SELL Open market or private sale	$308,665 $88.85 p/Share	3,474 Reduced 5.99%	54,539 Common Stock
Jan 20 2021	BUY Grant, award, or other acquisition	-	18,013 Added 23.69%	58,013 Common Stock

EJD

Edward J Dulac Iii

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Value

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

Operation

Value

Type

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE

Account